SOSV

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Michael Aberman

Partner

Lindsay Atkenson

Analyst

Hugh Bowen

Associate

Po Bronson

General Partner

Stephen Chambers

Partner

Navin Danapal

SEA Director

Hiruy Ephrem

Analyst

Sheng Ge

Partner, Investments Operations

Weichang Ge

Analyst

TR Harrington

Partner

Bill Liao

General Partner

Ching-Ping Lin

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Yuan-Ting Meng

Analyst

Paul Monaghan

Principal

Eric Ramsay

Analyst

Pae Wu

General Partner

Sabriya Stukes Ph.D

Partner

Past deals in Dental

DNALite Therapeutics

Convertible Note in 2023
DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

DNALite Therapeutics

Venture Round in 2022
DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Diadem Biotherapeutics

Convertible Note in 2021
Diadem Biotherapeutics is a biotechnology company that focuses on creating bio-therapeutical materials produced using organic means. Diadem develops exosomes to treat chronic inflammatory and auto-immune conditions.

Oralta

Seed Round in 2021
Oralta is a U.S.-based company that specializes in the manufacture of probiotic supplements aimed at improving oral health. Its flagship product, FRESH BREATH, consists of chewable tablets designed to combat bad breath by eliminating odor-causing bacteria while promoting the growth of beneficial probiotic strains. The tablets work by preventing the buildup of harmful germs, reducing their growth, and inactivating the byproducts responsible for unpleasant odors. Oralta's innovative approach focuses on restoring a healthy balance of oral bacteria, ultimately enhancing overall oral hygiene and addressing conditions such as tooth decay and gum disease.

DNALite Therapeutics

Convertible Note in 2021
DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Bravrr

Seed Round in 2020
Bravrr's first product, BruxRelief, is poised to disrupt the over $9B market of bruxism (unconscious teeth grinding) disorder. 1 in 3 people suffer from bruxism disorder, but sadly less than 10% are diagnosed or ever receive treatment. Worse yet, many patient only receive treatment after damage to their teeth has already occurred or they've developed severe jaw / neck pain, headaches, migraines, TMJ or tinnitus. The diagnostic devices that are on the market are vastly too complex and costly. Bravrr's BruxRelief wearable is an easy to use wearable headband that connects to your smartphone and provides analysis of your nightly bruxism behavior and sleeping patterns through and intuitively built app.

Lura Health

Convertible Note in 2020
Lura Health is a company that specializes in developing tooth-mounted sensors designed to monitor oral health through saliva analysis. Founded in 2016 and based in Cambridge, Massachusetts, Lura Health's wireless intra-oral sensors allow users to continuously track key diagnostic metrics related to their oral environment. The sensors are designed to sit comfortably on a single tooth and monitor oral acidity, transmitting data to a mobile application. This technology provides users with meaningful insights and instant feedback, empowering them to take control of their health and improve personal health management by setting and achieving health goals.

Xixilab

Seed Round in 2020
Xixilab Limited is a Hong Kong-based company that specializes in orthodontics and teeth whitening products. The company offers a range of dental technology designed to promote good dental care habits and enhance smiles. Its product line includes the Xixilab correction kit, which features braces, a toothbrush, a mouth opener, a retainer, and wax, as well as the Xixilab white kit, which contains a blue light, brightening pens, a maintenance pen, a restorative pen, a teeth color card, a user manual, and a travel bag. Founded in 2017, Xixilab partners with dental clinics and professionals to provide customized oral health products and services at competitive prices, emphasizing the importance of a confident smile in making a strong first impression.

Lura Health

Pre Seed Round in 2020
Lura Health is a company that specializes in developing tooth-mounted sensors designed to monitor oral health through saliva analysis. Founded in 2016 and based in Cambridge, Massachusetts, Lura Health's wireless intra-oral sensors allow users to continuously track key diagnostic metrics related to their oral environment. The sensors are designed to sit comfortably on a single tooth and monitor oral acidity, transmitting data to a mobile application. This technology provides users with meaningful insights and instant feedback, empowering them to take control of their health and improve personal health management by setting and achieving health goals.

UCHU Biosensors

Seed Round in 2019
UCHU Biosensors develops a platform of tooth mounted sensors to effortlessly track health through saliva.

Diadem Biotherapeutics

Seed Round in 2019
Diadem Biotherapeutics is a biotechnology company that focuses on creating bio-therapeutical materials produced using organic means. Diadem develops exosomes to treat chronic inflammatory and auto-immune conditions.

Dahlia Biosciences

Convertible Note in 2019
Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

DNALite Therapeutics

Seed Round in 2019
DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Bravrr

Pre Seed Round in 2019
Bravrr's first product, BruxRelief, is poised to disrupt the over $9B market of bruxism (unconscious teeth grinding) disorder. 1 in 3 people suffer from bruxism disorder, but sadly less than 10% are diagnosed or ever receive treatment. Worse yet, many patient only receive treatment after damage to their teeth has already occurred or they've developed severe jaw / neck pain, headaches, migraines, TMJ or tinnitus. The diagnostic devices that are on the market are vastly too complex and costly. Bravrr's BruxRelief wearable is an easy to use wearable headband that connects to your smartphone and provides analysis of your nightly bruxism behavior and sleeping patterns through and intuitively built app.

Dahlia Biosciences

Convertible Note in 2018
Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

DNALite Therapeutics

Seed Round in 2018
DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Mouth2Mouth

Seed Round in 2018
Mouth2Mouth is a healthcare startup that develops personalized probiotics for oral health. Based on microbiome data from thousands of healthy individuals, their AI-driven platform determines consortia of beneficial bacteria that fight widespread conditions such as tooth decay, gum disease, and bad breath. The company is on a mission to improve oral hygiene and provide a solution to oral diseases by use of an all-natural process.

Hippo and Crate

Seed Round in 2018
Hippo & Crate Limited is a company based in Jing'an, China, that specializes in oral and dental care products, including toothbrushes and toothpaste. Founded in 2016, it operates on a subscription-based direct-to-consumer model, offering high-quality and environmentally responsible oral hygiene products. The company aims to elevate personal care through aesthetically pleasing and effective items, catering to the growing demand for premium oral care solutions in China. By eliminating traditional retail channels, Hippo & Crate engages directly with consumers, fostering a loyal customer base through word-of-mouth marketing. The brand positions itself as a modern alternative to established players in the industry, reflecting a shift towards more personalized and accessible oral care options.

Daeki

Seed Round in 2017
Daeki has developed the saliva-based diabetes detection test, which provides a simple, quick and non-invasive alternative for patients to detect diabetes or prediabetes conditions at home.

Dahlia Biosciences

Seed Round in 2017
Dahlia Biosciences specializes in the fields of biotechnology and DNA analysis and diagnostics. The company provides a single-cell RNA analysis tools for research and diagnostic applications. Dahlia Biosciences was founded in 2011 and headquartered in California, United States.

DNALite Therapeutics

Seed Round in 2017
DNALite Therapeutics, Inc. is a biopharmaceutical company focused on developing gene therapy treatments specifically for the gastrointestinal tract. Founded in 2016 and based in San Francisco, California, the company utilizes proprietary technology to deliver therapeutic DNA directly to intestinal stem cells, aiming to address the underlying causes of diseases such as Familial Adenomatous Polyposis (FAP), a hereditary form of colorectal cancer that often necessitates invasive surgical procedures. By targeting these root causes, DNALite seeks to prevent disease progression rather than merely managing symptoms, offering a potentially transformative approach to treating gastrointestinal disorders, including colorectal cancer and Crohn's disease.

Kolibree

Series A in 2016
Kolibree SAS, founded in 2013 and based in Neuilly-sur-Seine, France, specializes in the development and manufacture of connected electric toothbrushes for both adults and children. Its smart toothbrushes utilize Bluetooth technology to connect with a mobile application, allowing users to track their brushing habits and identify neglected areas in their mouths. The company aims to enhance oral hygiene by creating engaging interactions between users and their connected devices. By offering real-time feedback and utilizing artificial intelligence, Kolibree's products motivate users to improve their dental care routines and help prevent common dental issues such as cavities and gum disease. The toothbrushes and replacement brush heads are available for purchase online.

Kolibree

Convertible Note in 2015
Kolibree SAS, founded in 2013 and based in Neuilly-sur-Seine, France, specializes in the development and manufacture of connected electric toothbrushes for both adults and children. Its smart toothbrushes utilize Bluetooth technology to connect with a mobile application, allowing users to track their brushing habits and identify neglected areas in their mouths. The company aims to enhance oral hygiene by creating engaging interactions between users and their connected devices. By offering real-time feedback and utilizing artificial intelligence, Kolibree's products motivate users to improve their dental care routines and help prevent common dental issues such as cavities and gum disease. The toothbrushes and replacement brush heads are available for purchase online.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.